Liu Wan-Cang, Gong Ting, Wang Qing-Hua, Liang Xiao, Chen Jing-Jing, Zhu Ping
State Key Laboratory of Bioactive Substance and Function of Natural Medicines; Institute of Materia Medica, Chinese Academy of Medical Sciences &Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, P.R. China.
Key Laboratory of Biosynthesis of Natural Products of National Health and Family Planning Commission, Institute of Materia Medica, Chinese Academy of Medical Sciences &Peking Union Medical College, 1 Xian Nong Tan Street, Beijing 100050, P.R. China.
Sci Rep. 2016 Jan 21;6:18439. doi: 10.1038/srep18439.
Scaling-up of high-cell-density fermentation (HCDF) of Pichia pastoris from the lab or pilot scale to the demonstration scale possesses great significance because the latter is the final technological hurdle in the decision to go commercial. However, related investigations have rarely been reported. In this paper, we study the scaling-up processes of a recombinant P. pastoris from the pilot (10 to 100-L) to the demonstration (1,000-L) scales, which can be used to convert 7-β-xylosyl-10-deacetyltaxol into 10-deacetyltaxol by the β-xylosidase for semi-synthesis of Taxol. We demonstrated that a pure oxygen supplement can be omitted from the HCDF if the super atmospheric pressure was increased from 0.05 to 0.10 ± 0.05 MPa, and we developed a new methanol feeding biomass-stat strategy (0.035 mL/g/h) with 1% dissolved oxygen and 100 g/L initial induction biomass (dry cell weight). The scaling-up was reproducible, and the best results were obtained from the 1,000-L scale, featuring a shorter induction time and the highest enzyme activities and productions, respectively. The specific growth and specific production rates were also determined. This study lays a solid foundation for the commercial preparation of 10-deacetyltaxol through the recombinant yeast. It also provides a successful paradigm for scaling-up HCDF of P. pastoris to the demonstration scale.
将毕赤酵母的高细胞密度发酵(HCDF)从实验室或中试规模扩大到示范规模具有重要意义,因为后者是决定商业化的最后一道技术障碍。然而,相关研究鲜有报道。在本文中,我们研究了重组毕赤酵母从10至100升的中试规模扩大到1000升示范规模的过程,该重组酵母可通过β-木糖苷酶将7-β-木糖基-10-脱乙酰紫杉醇转化为10-脱乙酰紫杉醇,用于紫杉醇的半合成。我们证明,如果将超大气压从0.05兆帕提高到0.10±0.05兆帕,高细胞密度发酵中可省略纯氧补充,并且我们开发了一种新的甲醇补料生物量控制策略(0.035毫升/克/小时),溶解氧为1%,初始诱导生物量为100克/升(干细胞重量)。扩大规模具有可重复性,在1000升规模下获得了最佳结果,分别具有较短的诱导时间以及最高的酶活性和产量。还测定了比生长速率和比生产率。本研究为通过重组酵母商业化制备10-脱乙酰紫杉醇奠定了坚实基础。它还为将毕赤酵母的高细胞密度发酵扩大到示范规模提供了一个成功范例。